Skip to main content
. 2023 Mar 13;14:1359. doi: 10.1038/s41467-023-36976-1

Table 2.

Median overall and progression-free survival

Part A (n = 69) Part B DLBCL (n = 23) Part C (n = 41)
Median OS, days (95% CI) 189 (161–258) 159 (101–NE) 508 (239–NE)
 Range 15–853 44–423 33–508
Median PFS, days (95% CI) 57 (52–81) 54 (49–65) 114 (84–239)
 Range 11–945 12–423 33–438

CI confidence interval, DLBCL diffuse large B-cell lymphoma, NE not estimable, OS overall survival, PFS progression-free survival.